Wave Life Sciences WVE Increase Decrease In Operating Lease Liabilities
Increase Decrease In Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept wve:IncreaseDecreaseInOperatingLeaseLiabilities.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's increase decrease in operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's increase decrease in operating lease liabilities?
- Wave Life Sciences (WVE) reported increase decrease in operating lease liabilities of -$2.05M in Q1 2026.
- How has Wave Life Sciences's increase decrease in operating lease liabilities changed year-over-year?
- Wave Life Sciences's increase decrease in operating lease liabilities decreased by 13.6% year-over-year, from -$1.81M to -$2.05M.
- What is the long-term trend for Wave Life Sciences's increase decrease in operating lease liabilities?
- Over 4 years (2021 to 2025), Wave Life Sciences's increase decrease in operating lease liabilities has grown at a 18.4% compound annual growth rate (CAGR), from -$3.89M to -$7.64M.
- What does increase decrease in operating lease liabilities mean?
- This represents the net change in the present value of future lease obligations for operating assets. It reflects the cash impact of lease payments made during the period relative to the recognition of lease liabilities. Monitoring this helps assess the company's long-term commitment to leased infrastructure and its impact on cash flow.